ZURICH, June 4, 2012 /PRNewswire/ --
The latest studies in the field of allergy and clinical immunology will be presented at the EAACI Congress 2012
- Japanese researchers will present findings on how stress affects the fetus during pregnancy
- Health Impacts of Airborne Allergen Information Network will present new findings on differences in pollen potency across Europe
- World's largest Congress on allergy & immunology with delegates from over 100 countries to present new ways of treating allergies
The European Academy of Allergy and Clinical Immunology (EAACI) will hold its annual congress 16 - 20 June in Geneva (Switzerland). The latest advances in the field of allergy and clinical immunology will be presented to specialists from around the world, making it the leading medical congress on allergy and immunology globally. Ground-breaking research results will be presented with the goals of reducing the impact of allergy by early detection, finding ways of prevention and improving the treatment of the growing number of patients.
Exposure to allergens during pregnancy will be a key topic during the EAACI Congress, as well as how stress provokes reactions such us as asthma or eczema in the newborn. Japanese researchers have found that anxiety in pregnant woman is associated with childhood atopic eczema during the first 8 months of life. The results will be presented at the Congress.
New findings will also be presented by the Health Impacts of Airborne Allergen Information Network (HIALINE project), showing the differences in pollen potency between European countries, and allowing better monitoring of allergies across Europe.
EAACI Congress 2012
The scientific programme includes an overview of the current practice trends and provides the best platform to communicate science and education. From "Childhood, the tipping point towards allergy", to "Revisiting the origins of allergy", the seven plenary symposia are focused on covering the most current topics in the field.
To complete the scientific agenda, an extensive programme full of sessions, courses, meetings and workshops will comprehensively address all areas of allergy and clinical immunology. More than 1,800 abstracts that represent the most recent discoveries in the field will be discussed in 39 oral presentation sessions and full day accessible poster sessions.
The European Academy of Allergy and Clinical Immunology, EAACI, is a non-profit organisation active in the field of allergic and immunologic diseases such as asthma, rhinitis, eczema, occupational allergy, food and drug allergy and anaphylaxis. EAACI was founded in 1956 in Florence and has become the largest medical association in Europe in the field of allergy and clinical immunology. It includes over 6'800 members from 121 countries, as well as 42 National Allergy Societies.
For more information, please contact:
Shepard Fox Communications
8002 Zurich - Switzerland
SOURCE European Academy of Allergy and Clinical Immunology (EAACI)